Systematic review of the risk of type 2 diabetes post therapy for early-stage breast cancer
Academia Oncology · 2024
DOI: 10.20935/acadonco6242 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Academia Oncology, 2024. Verfasst von Ilampirai Rathinam und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims
The purpose of this systematic review was to examine the risk of developing type 2 diabetes in cancer survivors undergoing adjuvant therapy and to collate and appraise the available evidence to provide clinicians with additional evidence to consider when choosing treatments for breast cancer patients.
Methods
MEDLINE, PubMed, EMBASE, and Scopus databases were searched. Articles describing the effects of adjuvant chemotherapy or endocrine therapy and how the treatments affected glucose and/or insulin resistance in women aged 18 years or older with breast cancer were included for analysis.
Results
Nine publications were included in this systematic review. No association was found between adjuvant chemotherapy and the use of aromatase inhibitors on the development of type 2 diabetes. In three out of five studies, long-term tamoxifen use was associated with an increased risk of developing type 2 diabetes.
Conclusion
There is some indication that long-term tamoxifen use is associated with an increased risk of developing type 2 diabetes in breast cancer patients. However, all studies were observational in nature. Further studies are needed to conclusively establish the relationship between this class of medication, treatment length, and the risk of type 2 diabetes in breast cancer survivors.
Zitieren
APA
Rathinam, I., Jin, L., Nguyen, A., Chen, J., & Preda, V. (2024). Systematic review of the risk of type 2 diabetes post therapy for early-stage breast cancer. Academia Oncology. https://doi.org/10.20935/acadonco6242
Vancouver
Rathinam I, Jin L, Nguyen A, Chen J, Preda V. Systematic review of the risk of type 2 diabetes post therapy for early-stage breast cancer. Academia Oncology. 2024. doi:10.20935/acadonco6242
BibTeX
@article{Rathinam2024,
author = {Rathinam, Ilampirai and Jin, Louise and Nguyen, Anna and Chen, Juliana and Preda, Veronica},
title = {Systematic review of the risk of type 2 diabetes post therapy for early-stage breast cancer},
journal = {Academia Oncology},
year = {2024},
doi = {10.20935/acadonco6242}
}
EUVIMED